
Apollo Endosurgery APEN
Annual report 2022
added 03-30-2023
Apollo Endosurgery Total Shareholders Equity 2011-2026 | APEN
Annual Total Shareholders Equity Apollo Endosurgery
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 32.6 M | 61.2 M | 6.75 M | 2.12 M | 28.8 M | 49.9 M | 42.4 M | 10.5 M | 15.8 M | 9.97 M | 14.9 M | 629 K |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 61.2 M | 629 K | 23 M |
Quarterly Total Shareholders Equity Apollo Endosurgery
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 42.3 M | - | 55 M | 61.2 M | -92 K | 2.71 M | 2.69 M | 6.75 M | 6.75 M | 6.75 M | 6.75 M | 2.12 M | 2.12 M | 2.12 M | 2.12 M | 28.8 M | 28.8 M | 28.8 M | 28.8 M | 49.9 M | 49.9 M | 49.9 M | 49.9 M | 42.4 M | 42.4 M | 42.4 M | 42.4 M | -134 M | 10.5 M | 10.5 M | 10.5 M | 15.8 M | 15.8 M | 15.8 M | 15.8 M | 9.97 M | 9.97 M | 9.97 M | 9.97 M | 14.9 M | 14.9 M | 14.9 M | 14.9 M | 629 K | 629 K | 629 K | 629 K |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 61.2 M | -134 M | 16.2 M |
Total Shareholders Equity of other stocks in the Medical devices industry
| Issuer | Total Shareholders Equity | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Alphatec Holdings
ATEC
|
12.4 M | $ 11.75 | - | $ 1.76 B | ||
|
BioSig Technologies
BSGM
|
-1.54 M | - | 37.08 % | $ 85.7 M | ||
|
Delcath Systems
DCTH
|
111 M | $ 8.98 | - | $ 322 M | ||
|
Axonics Modulation Technologies
AXNX
|
570 M | - | - | $ 3.31 B | ||
|
Aziyo Biologics
AZYO
|
27.7 M | - | 1.37 % | $ 20.5 M | ||
|
Acutus Medical
AFIB
|
-879 K | - | -26.83 % | $ 2.62 M | ||
|
Allied Healthcare Products
AHPI
|
5.23 M | - | 3.58 % | $ 2.21 M | ||
|
Second Sight Medical Products
EYES
|
17.6 M | - | -0.97 % | $ 54.4 M | ||
|
FONAR Corporation
FONR
|
150 M | $ 18.41 | - | $ 121 M | ||
|
Conformis
CFMS
|
54.2 M | - | - | $ 16.4 M | ||
|
Helius Medical Technologies
HSDT
|
2.35 M | $ 2.01 | - | $ 1.22 M | ||
|
Cardiovascular Systems
CSII
|
249 M | - | 0.15 % | $ 844 M | ||
|
IRIDEX Corporation
IRIX
|
9.52 M | $ 1.35 | - | $ 21.8 M | ||
|
Inogen
INGN
|
192 M | $ 6.32 | - | $ 168 M | ||
|
IRadimed Corporation
IRMD
|
94.6 M | $ 100.97 | - | $ 1.28 B | ||
|
Avinger
AVGR
|
-6.2 M | - | -20.74 % | $ 369 K | ||
|
LivaNova PLC
LIVN
|
1.2 B | $ 62.4 | - | $ 3.4 B | ||
|
LENSAR
LNSR
|
4.86 M | $ 5.56 | - | $ 64 M | ||
|
AxoGen
AXGN
|
129 M | $ 32.61 | - | $ 1.5 B | ||
|
CONMED Corporation
CNMD
|
1.03 B | $ 36.56 | - | $ 1.13 B | ||
|
Medtronic PLC
MDT
|
48 B | $ 86.58 | - | $ 111 B | ||
|
NanoVibronix
NAOV
|
627 K | - | - | $ 1.08 M | ||
|
Electromed
ELMD
|
43.2 M | $ 24.7 | - | $ 209 M | ||
|
Neovasc
NVCN
|
1.98 M | - | - | $ 111 M | ||
|
Cytosorbents Corporation
CTSO
|
11.1 M | $ 0.7 | - | $ 38.1 M | ||
|
Aethlon Medical
AEMD
|
5.12 M | $ 2.16 | - | $ 3.37 M | ||
|
InspireMD
NSPR
|
55.2 M | $ 1.79 | 3.47 % | $ 115 M | ||
|
Profound Medical Corp.
PROF
|
97.4 M | $ 5.15 | - | $ 180 M | ||
|
BIOLASE
BIOL
|
-247 K | - | -13.19 % | $ 166 K | ||
|
Orthofix Medical
OFIX
|
450 M | $ 11.72 | - | $ 464 M | ||
|
AdaptHealth Corp.
AHCO
|
1.52 B | $ 11.48 | - | $ 1.55 B | ||
|
Myomo
MYO
|
11.4 M | $ 0.7 | - | $ 29.3 M | ||
|
Penumbra
PEN
|
1.43 B | $ 334.17 | - | $ 13 B | ||
|
Nano-X Imaging Ltd.
NNOX
|
189 M | $ 2.4 | - | $ 141 M | ||
|
Invacare Corporation
IVC
|
81.1 M | - | - | $ 24.7 M | ||
|
EDAP TMS S.A.
EDAP
|
40.9 M | $ 3.91 | - | $ 146 M | ||
|
Insulet Corporation
PODD
|
1.52 B | $ 225.5 | - | $ 15.9 B | ||
|
Quanterix Corporation
QTRX
|
296 M | $ 3.82 | - | $ 163 M | ||
|
OrthoPediatrics Corp.
KIDS
|
347 M | $ 15.91 | - | $ 373 M |